Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$9,348,635
+$1,130,318 QoQ
Shares Held
36,810
+9.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
#1,154
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aviance Capital Partners, LLC holds $78,033,539 across 10 Drug Manufacturers - General names. JNJ ranks #3 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
147,328 | $37,073,617 | |
| 2 | AMGN |
Amgen Inc
|
36,998 | $13,397,715 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
36,810 | $9,348,635 | |
| 4 | MRK |
Merck & Co., Inc.
|
42,110 | $5,411,135 | |
| 5 | PFE |
Pfizer Inc
|
159,351 | $3,837,172 | |
| 6 | LLY |
ELI LILLY & Co
|
3,181 | $3,815,387 | |
| 7 | NVO |
Novo Nordisk A S
|
49,981 | $2,396,089 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
32,102 | $1,849,717 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,348,635 | 36,810 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $8,218,317 | 33,621 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $6,783,614 | 32,779 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $6,126,276 | 33,040 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $6,117,637 | 40,050 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $6,570,580 | 39,620 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $5,858,122 | 40,507 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $6,244,982 | 38,535 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $5,729,472 | 39,200 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $5,982,429 | 37,818 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $3,629,314 | 23,155 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $3,689,561 | 23,689 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $4,093,640 | 24,732 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $3,780,915 | 24,393 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,195,614 | 23,751 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $3,822,624 | 23,400 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $4,335,504 | 24,424 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $4,147,536 | 23,402 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $3,997,563 | 23,368 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $3,806,232 | 23,568 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,920,647 | 23,799 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $3,907,421 | 23,775 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $3,666,954 | 23,300 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,470,392 | 23,310 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $3,227,458 | 22,950 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $3,010,875 | 22,961 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||